Pages
Products

Plant-based Protein Production Service

OverviewExpression SystemsTechnology WorkflowCollaboration ModelsContact Us

Overview

Plant-based expression systems are evolving from so-called "alternative solutions" into an independent and increasingly important pillar of modern biomanufacturing. In scenarios where microbial or mammalian cell expression systems are constrained, plant-based platforms are demonstrating distinctive advantages in preserving complex protein structures, ensuring biosafety, and enabling cost-effective scale-up.

Built upon multiple plant expression modalities, Creative Biogene has established an integrated technology platform spanning gene design, expression strategy selection, scale-up production, protein purification, and quality characterization. We provide customized plant-derived recombinant protein services for global clients across both research and translational development stages.

Why Choose Plant-Based Expression Systems?

Plant-based expression is not a "low-end substitute," but rather a differentiated solution, particularly suitable for the following applications:

  • Proteins that tend to form inclusion bodies, lose activity, or undergo misfolding in microbial systems
  • Functional proteins requiring specific glycosylation patterns, higher-order conformations, or multimeric assembly
  • Applications with stringent biosafety requirements, where endotoxin contamination and human pathogen risks must be avoided
  • Projects requiring rapid scale-up without the extended timelines and high costs associated with mammalian cell line development

Compared with conventional expression systems, plant-based platforms offer multiple systemic advantages. They feature a lighter cost structure, more flexible scale-up pathways, and an inherent absence of mammalian viral contamination risks. In addition, the unique organelle architecture of plant cells provides a cellular environment that more closely resembles native conditions for the proper folding and post-translational modification of complex proteins.

Core Plant-Based Expression Technology Systems

At the platform level, Creative Biogene has established a technology framework centered on plant cell–based expression and tissue-specific expression systems, further extended to encompass a broad range of plant-derived expression modalities.

Plant Cell Suspension Culture Expression System

Optimized plant cell suspension cultures enable efficient production of functional proteins, enzymes, and selected therapeutics, providing a reliable platform for pilot-scale production and downstream industrial applications.

Rice Endosperm–Specific Expression System

Endosperm-specific promoters drive high protein accumulation without affecting plant growth. Proteins are stored in seeds, offering superior stability and ease of transport. This system is ideal for recombinant human serum albumin, vaccine antigens, and oral protein formulations.

Whole-Plant Transient and Stable Expression Systems

Model plants like tobacco and lettuce provide flexible whole-plant platforms. Transient expression allows rapid protein production for feasibility studies, antigen screening, and early-stage research, while stable expression supports long-term protein supply through transgenic lines.

  • Tobacco transient and stable expression system
  • Lettuce transient and stable expression system

Additional Plant-Derived Expression Platforms

Creative Biogene also offers alternative plant-based systems to meet specialized needs, including:

  • Plant hairy root cultures
  • Microalgal expression systems
  • Wheat germ cell-free expression systems

Technology Workflow and Platform Architecture

In plant-based expression, technological differentiation lies not merely in the ability to achieve transformation, but in the capacity to operate a fully integrated and systematic platform. This includes early-stage feasibility assessment, rational expression strategy design, scalable process development, and consistent delivery of qualified protein products. Creative Biogene approaches plant expression as an end-to-end engineering system rather than a single experimental service, and has built a modular, combinable plant expression platform around this philosophy.

01 Expression Strategy Design and Project Feasibility Assessment

The success of plant-based expression is highly dependent on upfront strategic decisions. For each project, platform development begins with a systematic analysis of the target protein rather than immediate experimental execution.

  • Target protein property analysis
  • Expression system matching and technical risk assessment
  • Application-driven expression strategy design

02 Gene Design and Expression Construct Development

During the construct development phase, Creative Biogene employs a combination of standardized methodologies and customized design strategies to ensure both expression efficiency and system stability.

  • Gene synthesis and codon optimization
  • Selection of promoters and regulatory elements
  • Subcellular targeting and signal peptide design

03 Plant Transformation and Expression Validation

Following construct assembly, the platform proceeds to plant system delivery and expression validation, serving as the critical bridge between design and production.

  • Introduction to plant expression systems
  • Screening and preliminary identification of positive materials
  • Evaluation of expression level and stability

04 Scale-Up Expression and Process Optimization

For projects that pass expression validation, the platform offers scale-up and production-level process development support.

  • Optimization of expression conditions and culture parameters
  • Design of scalable production pathways
  • Control of batch consistency and reproducibility

05 Protein Extraction, Purification, and Quality Characterization

The ultimate goal of the plant-based expression platform is to deliver functional, verifiable protein products rather than expression data alone.

  • Processing of plant biomass and protein extraction
  • Development of purification workflows
  • Protein quality analysis and characterization

Collaboration Models

Creative Biogene's plant-based expression platform supports multiple levels of collaboration, ranging from early feasibility validation to long-term production partnerships. Clients may select engagement models that best align with their development objectives.

  • Expression feasibility validation and method establishment
  • Small-scale protein production and research-grade delivery
  • Pilot-scale production and process development support
  • Long-term expression system development and continuous supply solutions

Platform Vision

Creative Biogene is committed to building plant-based expression platforms into a critical bridge between fundamental research and industrial translation. Through continuous advancement of plant chassis engineering, expression strategy design, and downstream processing technologies, we aim to help our clients achieve an optimal balance between biosafety, cost efficiency, and scalable production—accelerating the transition of plant-derived recombinant proteins from the laboratory to real-world applications. For more information on expression system selection and service details, please feel free to contact us.

FAQ

Q1: What protein yields can be expected from plant expression systems?

A: Yields vary depending on the protein properties and the chosen expression system, ranging from milligrams to grams. Transient expression systems, such as in tobacco leaves, allow rapid production of research-scale protein within 2–3 weeks. Stable transgenic plants or plant cell suspension cultures are better suited for medium to large-scale production, enabling continuous generation of high-yield protein.

Q2: How is the purity and activity of plant-expressed proteins ensured?

A: We employ multi-step purification strategies, including affinity chromatography, ion exchange, and size-exclusion chromatography, to achieve protein purity meeting research or clinical standards. Purified proteins are assessed by SDS-PAGE, electrophoresis, and functional activity assays. Where needed, stability analysis and custom formulations can be provided to ensure optimal downstream performance.

Q3: Can clients provide specific design requirements for tags or fusion proteins?

A: Yes, we support a wide range of tags (e.g., His-tag, FLAG-tag, Fc-fusion) and fusion strategies to facilitate purification, detection, or functional enhancement. Tag type and positioning can be confirmed with the client during the design phase to ensure optimal expression and functional balance.

Q4: Can plant expression systems be used for oral protein therapeutics or functional foods?

A: Yes, certain plant systems, such as rice endosperm or microalgae, can produce proteins suitable for oral administration. This approach leverages the natural protective mechanisms of plant proteins to enhance stability in the digestive tract, offering potential for oral vaccines or functional food development.

Q5: How are intellectual property and confidentiality protected?

A: We strictly adhere to non-disclosure agreements (NDAs) and client IP protection requirements. All gene sequences, expression vectors, and production data remain the property of the client. Project materials are used solely for the commissioned R&D services, ensuring the security of both commercial and scientific information.

Quick Inquiry